Get Live Data

Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. MaxCyte Share Price
  4. MaxCyte Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksMaxCyte Share News (MXCT)

MaxCyte Information

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.00
Bid: 340.00
Ask: 350.00
Change: -12.00 (-3.36%)
Spread: 10.00 (2.941%)
Open: 355.00
High: 355.00
Low: 345.00
Prev. Close: 357.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Mon, 14th Sep 2020 15:44

Tuesday 15 September 
Smart Metering Systems PLCHalf Year Results
JTC PLCHalf Year Results
Ocado Group PLCQ3 Results
Chemring Group plcQ3 Results
Vectura Group plcHalf Year Results
Marshalls PLCHalf Year Results
Polypipe Group PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Bonhill Group PLCHalf Year Results
Diurnal Group PLCFull Year Results
Corero Network Security PLCHalf Year Results
Good Energy Group PLCHalf Year Results
Trinity Exploration & Production PLCHalf Year Results
SimplyBiz Group PLCHalf Year Results
Wednesday 16 September 
Ocean Outdoor LtdHalf Year Results
Futura Medical PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
accesso Technology Group PLCHalf Year Results
Boku IncHalf Year Results
Central Asia Metals PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
Ormonde Mining PLCHalf Year Results
Loungers PLCFull Year Results
Redrow PLCFull Year Results
Redde Northgate PLCFull Year Results
Pebble Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Galliford Try Holdings PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
Thursday 17 September 
Duke Royalty LtdFull Year Results
Spire Healthcare Group PLCHalf Year Results
Supermarket Income REIT PLCFull Year Results
Next PLCHalf Year Results
Oxford Biomedica PLCHalf Year Results
Clinigen Group PLCFull Year Results
ThinkSmart LtdFull Year Results
Trainline PLCTrading Statement
Safestyle UK PLCHalf Year Results
Wilmington PLCFull Year Results
Kier Group PLCFull Year Results
Keywords Studios plcHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Hilton Food Group PLCHalf Year Results
Playtech PLCHalf Year Results
Friday 18 September 
Applegreen PLCHalf Year Results
Investec PLCTrading Statement
Monday 21 September 
Pennant International Group PLCHalf Year Results
MaxCyte IncHalf Year Results
Informa PLCHalf Year Results
Dunedin Enterprise Investment Trust PLCHalf Year Results
Avon Rubber PLCTrading Statement
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Apr 2020 14:54

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

Read more
21 Feb 2020 11:53

MaxCyte to consolidate stock to single trading line

(Sharecast News) - Life sciences company MaxCyte announced the consolidation of its two lines of common stock into a single unrestricted line of common stock on Friday.

Read more
20 Jan 2020 10:58

MaxCyte 'exceptionally positive' following strong FY trading performance

(Sharecast News) - Clinical-stage life sciences company MaxCyte told investors on Monday that its board was "exceptionally positive" of the group's future following a stellar year.

Read more
20 Jan 2020 09:00

MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue

MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue

Read more
4 Dec 2019 16:14

MaxCyte inks new development agreement with KSQ Therapeutics

(Sharecast News) - Cell-based therapeutics and life sciences company MaxCyte has entered into a new development and commercialisation agreement with its existing partner KSQ Therapeutics, it announced on Wednesday.

Read more
4 Dec 2019 11:50

MaxCyte Shares Rise As It Signs Development Deal With KSQ Therapeutics

MaxCyte Shares Rise As It Signs Development Deal With KSQ Therapeutics

Read more
21 Nov 2019 18:55

MaxCyte Inks Non-Exclusive Licence Agreement With Vor Biopharma

MaxCyte Inks Non-Exclusive Licence Agreement With Vor Biopharma

Read more
21 Nov 2019 16:40

MaxCyte strikes deal with oncology company Vor Biopharma

(Sharecast News) - Cell-based therapies and life sciences company MaxCyte announced a clinical and commercial licence agreement with oncology company Vor Biopharma on Thursday, under which Vor would use MaxCyte's 'Flow Electroporation' technology to produce engineered hematopoietic stem cells (eHSCs), and initiate investigational new drug-enabling studies to accelerate its progress towards the clinic.

Read more
24 Oct 2019 12:53

MaxCyte Advances Phase I Clinical Trial Of Cancer Drug MCY-M11

MaxCyte Advances Phase I Clinical Trial Of Cancer Drug MCY-M11

Read more
7 Oct 2019 12:23

MaxCyte And Editas Ink Five Medicine Licence Deal, EDIT-301 Included

MaxCyte And Editas Ink Five Medicine Licence Deal, EDIT-301 Included

Read more
18 Sep 2019 11:59

MaxCyte Interim Rises Revenue But Loss Widens On CARMA Investment

(Alliance News) - Life sciences company MaxCyte Inc on Wednesday reported first half revenue growth but its loss widened as expenses soared.In the six months to June 30, the firm's rose

Read more
11 Sep 2019 16:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 12 September WM Morrison SupermarketsHalf Year ResultsBrooks MacdonaldFull Year

Read more
17 Jul 2019 13:43

MaxCyte Progresses On MCY-M11 Development As Interim Revenue Rises

(Alliance News) - MaxCyte Inc on Wednesday reported double-digit revenue growth in the first half of 2019 and expects to see continued progress throughout the second half of the year.The is

Read more
26 May 2019 21:53

Sunday share tips: IQE, MaxCyte

(Sharecast News) - In his 'Inside the City' column for The Sunday Times, Ben Woods looked at the effect of Donald Trump's posturing against Huawei on the chipmaking industry - particularly, wafer semiconductor technology minnow IQE.

Read more
8 May 2019 15:58

MaxCyte begins dosing second cohort in MCY-M11 clinical trial

(Sharecast News) - Clinical-stage, cell-based therapies and life sciences company MaxCyte has initiated dosing for the second cohort of patients in its US phase 1 clinical trial with MCY-M11 - the lead, wholly-owned, non-viral mRNA-based cell therapy candidate from its CARMA platform - it announced on Wednesday.

Read more
234567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.